Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation

Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation

Kanqiu Jiang,* Mingjing Shen,* Weihua Xu Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou Shi, Jiangsu Sheng, People’s Republic of China *These authors contributed equally to this work Purpose: In this study, a novel arginine, glycine, a...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Jiang K, Shen M, Xu W
Materialtyp: Artikel
Språk:English
Publicerad: Dove Medical Press 2018-04-01
Serie:International Journal of Nanomedicine
Ämnen:
RGD
Paclitaxel
Curcumin
liposome
Cell uptake
Cytotoxicity study
In vivo anti-tumor study
Länkar:https://www.dovepress.com/arginine-glycine-aspartic-acid-peptide-modified-paclitaxel-and-curcumi-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/arginine-glycine-aspartic-acid-peptide-modified-paclitaxel-and-curcumi-peer-reviewed-article-IJN

Liknande verk